Form 4: Astrana Health CMO Sells Shares for Tax Obligations

Astrana Health's Chief Medical Officer, Dinesh M. Kumar, disposed of 5,102 shares of common stock to cover tax withholding obligations related to vested restricted stock.

Summary

• Dinesh M. Kumar, Chief Medical Officer of Astrana Health, Inc. (ASTH), reported a transaction on January 1, 2026.
• The transaction involved the disposition of 5,102 shares of common stock at a price of $24.81 per share.
• This disposition was a surrender of shares to offset tax withholding obligations associated with certain shares of restricted stock that vested on January 1, 2026.
• Following this transaction, Mr. Kumar beneficially owns 212,791 shares of common stock.
• The beneficially owned shares include 56,754 restricted shares, which will vest in two equal annual installments beginning on January 23, 2026, subject to continuous employment.
• Additional grants of 8,158 shares and 3,264 shares of restricted stock will vest subject to the achievement of certain performance goals.
• Beneficial ownership also includes 67,238 restricted stock units (RSUs) that will vest subject to the achievement of certain performance goals.
• Another 23,364 restricted stock units will vest in seven equal semi-annual installments beginning on March 5, 2026, subject to continuous employment.
• The total beneficial ownership also includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary disposition of shares to cover tax withholding obligations upon the vesting of restricted stock. It does not indicate a change in management's outlook or a strategic move.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction for tax purposes and does not provide specific insights into broader industry trends or the competitive landscape for the healthcare services sector.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary transaction for tax purposes, not a sale driven by investment decisions.
• No direct impact on employees, customers, suppliers, or creditors is indicated by this filing.

Key Dates

Keywords

Astrana Health, ASTH, Dinesh M. Kumar, Chief Medical Officer, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock, RSU, Employee Stock Purchase Plan